drugset / Trial / NCT04797377

Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response

NCT04797377 ↗

Completed 66 enrolled Nadezhda Women's Health Hospital
NaSingle-groupOpen-labelTreatment

Summary

Reproductive age women diagnosed with poor ovarian response (POR) based on Bologna criteria with a history of at least two prior failed ICSI cycle will be recruited for the study. Antral follicle count (AFC), serum anti-mullerian hormone (AMH), and early follicular phase serum follicle stimulating hormone (FSH) levels will determined at baseline. Autologous blood obtained from peripheral vein will be used to prepare PRP following standard protocols and will be injected to both ovaries. Ovarian reserve parameters and ICSI outcomes will be determined.

Timeline

Start
2021-03-16
Primary completion
2021-09-04
Completion
2021-09-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP Unknown 0.5 ml Other

Indications